Envista CEO Amir Aghdaei said while speaking at the Evercore ISI healthcare conference, in response to a question about product demand: "Overall, a little bit of a slowdown in North America, but not as pronounced as what we see in Europe. In Europe, there is a distinct slowdown, it’s obvious. You can see it on the patient volume, on the spending, on various expansion opportunities. So you add those 2 together, that’s about 70%, 75% of our business as a whole. China, very choppy. We really cannot predict what is taking place. We came out of Shanghai lockdown, a ramp in Q3. In the past, probably 4, 6 weeks, we have seen a significant slowdown. Various sites are getting closed. You’ve heard all the things that we are hearing, the riots, slowdown, other places, number of COVID is going down. It’s really hard to forecast the realities on the ground in China… That combination of what you see on the ground plus the government action has caused China as a whole to come to a more of a pause situs. And obviously, the Russia, anybody’s call. We had significant growth in Q1, significant decline in Q2 because we couldn’t get any product fees, ramp back up in Q3, ramp back down in Q4… So about 14% of our business is in China and Russia, really hard to call it. So the long-term perspective continues to be very positive. We are bullish about it, but the short term is really choppy. It’s difficult to call it because of this macro elements that I talked about."
Published first on TheFly
